ARNI Data and its Implications on Clinical Practice, Radcliffe Cardiology

Views:
2077
Likes:
7

Part 3 of 3

< Prev

Safety and Efficacy of ARNI Therapy in Acute Heart Failure

Azmee Modh Ghazi, David Morrow

Overview

This educational programme focuses on placing recent data on ARNIs in Heart Failure into perspective for a Malaysian audience

This programme was supported by an unrestricted educational grant from Novartis.

More from this programme

Part 1

Local Interpretation of Emerging ARNI Data in HF

2 sessions
Meet the Expert Presentation	Watch now
Meet the Expert Q&A	Watch now

Part 2

Managing Hypotension in Patients with HFrEF (Utilising ARNIs)

1 session
Expert Interview	Watch now

Part 3

Clinical Questions on ARNI therapy

5 sessions
Local Interpretation of Emerging ARNI Data in HF	Watch now
ARNI Therapy Mode of Action	Watch now
Safety and Efficacy of ARNI Therapy in Acute Heart Failure	Watch now
When to Initiate ARNI Therapy in Acute Heart Failure	Watch now
Summary	Watch now

Faculty Biographies

Azmee Modh Ghazi

Dr Azmee Mohd Ghazi is a Cardiologist at the National Heart Centre, Malaysia, where he serves as Clinical Director for Heart Failure and Heart Transplant. Specialising in coronary intervention, cardiac transplantation, advanced adult heart failure and pulmonary hypertension, Dr Azmee undertakes a number of procedures including coronary intervention (PCI), right heart catheterisation, and echocardiography.

View full profile

David Morrow

Prof David A Morrow the Director of the Samuel A. Levine Cardiac Intensive Care Unit in the Division of Cardiovascular Medicine at Brigham and Women's Hospital and a Professor of Medicine at Harvard Medical School. He directs the TIMI Biomarker Program